|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Fortress Biotech, Inc. (FBIO) |
|
|
$0.29 0.00 (0.00%) as of 4:30 Mon 10/9
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
93,700,000 |
Market
Cap: |
26.82(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.2833 - $0.327 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates. Through its partner company, Co. markets dermatology products including Qbrexza®, which is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane® (isotretinoin) capsule, which is an oral retinoid indicated for the treatment of severe recalcitrant nodular acne; as well as Ximino® (minocycline hydrochloride) extended release capsule, which is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
35,500 |
45,500 |
1,910,073 |
6,092,167 |
Total Buy Value |
$147,628 |
$165,217 |
$3,227,092 |
$6,881,051 |
Total People Bought |
2 |
2 |
3 |
6 |
Total Buy Transactions |
5 |
6 |
10 |
22 |
Total Shares Sold |
0 |
10,000 |
10,000 |
10,000 |
Total Sell Value |
$0 |
$18,900 |
$18,900 |
$18,900 |
Total People Sold |
0 |
1 |
1 |
1 |
Total Sell Transactions |
0 |
1 |
1 |
1 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Avgerinos George |
SVP, BIOLOGICS OPERATIONS |
|
2018-12-11 |
4 |
S |
$1.05 |
$102,191 |
D/D |
(97,325) |
255,170 |
|
- |
|
Rosenwald Lindsay A Md |
PRESIDENT AND CEO |
|
2018-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
7,524,693 |
|
- |
|
Hunter Robyn |
Chief Financial Officer |
|
2018-11-23 |
4 |
S |
$1.29 |
$26,277 |
D/D |
(20,370) |
239,759 |
|
- |
|
Weiss Michael S |
EXECUTIVE VICE CHAIRMAN |
|
2018-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
164,473 |
8,752,071 |
|
- |
|
Rosenwald Lindsay A Md |
PRESIDENT AND CEO |
|
2018-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
164,473 |
7,523,179 |
|
- |
|
Klein Dov |
Director |
|
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
355,000 |
|
- |
|
Weiss Michael S |
EXECUTIVE VICE CHAIRMAN |
|
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
586,428 |
8,587,598 |
|
- |
|
Rosenwald Lindsay A Md |
PRESIDENT AND CEO |
|
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
586,428 |
7,358,706 |
|
- |
|
Rowinsky Eric K |
Director |
|
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
450,000 |
|
- |
|
Lobell J Jay |
Director |
|
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
786,000 |
|
- |
|
Harvey Jimmie |
Director |
|
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
450,000 |
|
- |
|
Hoenlein Malcolm |
Director |
|
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
285,000 |
|
- |
|
Avgerinos George |
SVP, BIOLOGICS OPERATIONS |
|
2017-12-14 |
4 |
S |
$3.55 |
$42,600 |
D/D |
(12,000) |
352,495 |
|
- |
|
Avgerinos George |
SVP, BIOLOGICS OPERATIONS |
|
2017-12-13 |
4 |
S |
$3.57 |
$67,830 |
D/D |
(19,000) |
364,495 |
|
- |
|
Avgerinos George |
SVP, BIOLOGICS OPERATIONS |
|
2017-12-12 |
4 |
S |
$3.59 |
$91,879 |
D/D |
(25,593) |
383,495 |
|
- |
|
Avgerinos George |
SVP, BIOLOGICS OPERATIONS |
|
2017-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
409,088 |
|
- |
|
Rosenwald Lindsay A Md |
PRESIDENT, CEO |
|
2017-11-06 |
4 |
B |
$25.00 |
$1,000,000 |
D/D |
40,000 |
40,000 |
3.23 |
- |
|
Klein Dov |
Director |
|
2017-07-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,333) |
201,668 |
|
- |
|
Weiss Michael S |
Exec. VC - Strategic Dev. |
|
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
552,698 |
8,001,170 |
|
- |
|
Rosenwald Lindsay A Md |
President and CEO |
|
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
552,698 |
5,857,168 |
|
- |
|
Lobell J Jay |
Director |
|
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
686,000 |
|
- |
|
Rowinsky Eric K |
Director |
|
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
350,000 |
|
- |
|
Klein Dov |
Director |
|
2017-01-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,666) |
215,001 |
|
- |
|
Klein Dov |
Director |
|
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
241,667 |
|
- |
|
Rosenwald Lindsay A Md |
President and CEO |
|
2016-12-01 |
4 |
B |
$2.03 |
$1,484 |
D/D |
731 |
5,304,470 |
3.15 |
- |
|
158 Records found
|
|
Page 5 of 7 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|